Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)OVSTAR TIL Trial (OVarian Cancer Co-STimulatory Antigen Receptor TIL Trial)
Phase 1
Withdrawn
- Conditions
- Ovarian Cancer Metastatic
- Interventions
- Genetic: Gene modified Tumour Infiltrating Lymphocytes (CoTIL-01)Genetic: Unmodified Tumour Infiltrating Lymphocytes (UTIL-01)
- First Posted Date
- 2020-05-15
- Last Posted Date
- 2020-12-16
- Lead Sponsor
- Immetacyte Ltd
- Registration Number
- NCT04389229
- Locations
- 🇬🇧
Queens Elizabeth Hospital, Birmingham, United Kingdom
🇬🇧The Christies Hospital, Manchester, United Kingdom
News
No news found